Overview of antimicrobial therapy in intensive care units

References

• Vincent J, Rello J, Marshall J et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA302(21), 2323–2329 (2009).
   PubMed Web of Science ®Google Scholar
• Kumar A, Roberts D, Wood KE et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med.34(6), 1589–1596 (2006).
   PubMed Web of Science ®Google Scholar
• Yu VL, Singh N. Excessive antimicrobial usage causes measurable harm to patients with suspected ventilator-associated pneumonia. Intensive Care Med.30(5), 735–738 (2004).
   PubMed Web of Science ®Google Scholar
• Leone M, Bourgoin A, Cambon S, Dubuc M, Albanèse J, Martin C. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit. Care Med.31(2), 462–467 (2003).
   PubMed Web of Science ®Google Scholar
• Leone M, Garcin F, Bouvenot J et al. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse. Crit. Care Med.35(2), 379–385; quiz 386 (2007).
   PubMed Web of Science ®Google Scholar
• Alvarez-Lerma F, Alvarez B, Luque P et al. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study. Crit. Care.10(3), R78 (2006).
   PubMed Web of Science ®Google Scholar
• Wick JY. Enigmatic, but understandable: empiric therapy. Consult. Pharm.22(8), 691–694 (2007).
   PubMedGoogle Scholar
• Leone M, Garcin F, Bouvenot J et al. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse. Crit. Care Med.35(2), 379–385; quiz 386 (2007).
   PubMed Web of Science ®Google Scholar
• Leone M, Bourgoin A, Cambon S, Dubuc M, Albanèse J, Martin C. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit. Care Med.31(2), 462–467 (2003).
   PubMed Web of Science ®Google Scholar
• Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest122(1), 262–268 (2002).
   PubMed Web of Science ®Google Scholar
• Luna CM, Vujacich P, Niederman MS et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest111(3), 676–685 (1997).
   PubMed Web of Science ®Google Scholar
• Lodise TP, Patel N, Kwa A et al. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob. Agents Chemother.51(10), 3510–3515 (2007).
   PubMed Web of Science ®Google Scholar
• American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med.171(4), 388–416 (2005).
   PubMed Web of Science ®Google Scholar
• Tam VH, Gamez EA, Weston JS et al. Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin–tazobactam: implications on the appropriateness of the resistance breakpoint. Clin. Infect. Dis.46(6), 862–867 (2008).
   PubMed Web of Science ®Google Scholar
• Garcin F, Leone M, Antonini F, Charvet A, Albanèse J, Martin C. Non-adherence to guidelines: an avoidable cause of failure of empirical antimicrobial therapy in the presence of difficult-to-treat bacteria. Intensive Care Med.36(1), 75–82 (2010).
   PubMed Web of Science ®Google Scholar
• Nachtigall I, Tamarkin A, Tafelski S et al. Impact of adherence to standard operating procedures for pneumonia on outcome of intensive care unit patients. Crit. Care Med.37(1), 159–166 (2009).
   PubMed Web of Science ®Google Scholar
• Cabana MD, Rand CS, Powe NR et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA282(15), 1458–1465 (1999).
   PubMed Web of Science ®Google Scholar
• Fagon JY, Chastre J, Wolff M et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann. Intern. Med.132(8), 621–630 (2000).
   PubMed Web of Science ®Google Scholar
• Osih RB, McGregor JC, Rich SE et al. Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia. Antimicrob. Agents Chemother.51(3), 839–844 (2007).
   PubMed Web of Science ®Google Scholar
• Thom KA, Schweizer ML, Osih RB et al. Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study. BMC Infect. Dis.8, 116 (2008).
   PubMedGoogle Scholar
• Bouza E, Muñoz P. Epidemiology of candidemia in intensive care units. Int. J. Antimicrob. Agents.2(Suppl. 2), S87–S91 (2008).
   Google Scholar
• Schelenz S. Management of candidiasis in the intensive care unit. J. Antimicrob. Chemother.61(Suppl. 1), i31–i34 (2008).
   Google Scholar
• Leone M, Martin C. Starting and stopping antibiotic therapy. In: Controversies in Intensive Care Medicine. Kuhlen R, Moreno R, Ranieri M, Rhodes A (Eds). MWV Medizinisch Wissenschaftliche Verlagsgesellschaft OHG, Berlin, 219–226 (2008).
   Google Scholar
• Calandra T, Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit. Care Med.33(7), 1538–1548 (2005).
   PubMed Web of Science ®Google Scholar
• Dellinger RP, Levy MM, Carlet JM et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med.36(1), 296–327 (2008).
   PubMed Web of Science ®Google Scholar
• Levy MM, Dellinger RP, Townsend SR et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med.36(2), 222–231 (2010).
   PubMed Web of Science ®Google Scholar
• Gaieski DF, Mikkelsen ME, Band RA et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit. Care Med.38(4), 1045–1053 (2010).
   PubMed Web of Science ®Google Scholar
• Ferrer R, Artigas A, Suarez D et al. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am. J. Respir. Crit. Care Med.180(9), 861–866 (2009).
   PubMed Web of Science ®Google Scholar
• Kumar A, Ellis P, Arabi Y et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest136(5), 1237–1248 (2009).
   PubMed Web of Science ®Google Scholar
• Auburtin M, Wolff M, Charpentier J et al. Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit. Care Med.34(11), 2758–2765 (2006).
   PubMed Web of Science ®Google Scholar
• Brigden ML, Pattullo AL. Prevention and management of overwhelming postsplenectomy infection – an update. Crit. Care Med.27(4), 836–842 (1999).
   PubMed Web of Science ®Google Scholar
• Michel F, Franceschini B, Berger P et al. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest127(2), 589–597 (2005).
   PubMed Web of Science ®Google Scholar
• Syrjälä H, Broas M, Suramo I, Ojala A, Lähde S. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin. Infect. Dis.27(2), 358–363 (1998).
   PubMed Web of Science ®Google Scholar
• Lichtenstein DA. Point-of-care ultrasound: infection control in the intensive care unit. Crit. Care Med.35(Suppl. 5), S262–S267 (2007).
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis.44(Suppl. 2). S27–S72 (2007).
   PubMed Web of Science ®Google Scholar
• Arnold FW, LaJoie AS, Brock GN et al. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arch. Intern. Med.169(16), 1515–1524 (2009).
   PubMedGoogle Scholar
• Frei CR, Attridge RT, Mortensen EM et al. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Clin. Ther.32(2), 293–299 (2010).
   PubMed Web of Science ®Google Scholar
• Menéndez R, Torres A, Zalacaín R et al. Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am. J. Respir. Crit. Care Med.172(6), 757–762 (2005).
   PubMed Web of Science ®Google Scholar
• Fàbregas N, Ewig S, Torres A et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax54(10), 867–873 (1999).
   PubMed Web of Science ®Google Scholar
• Torres A, Ewig S, Lode H, Carlet J. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med.35(1), 9–29 (2009).
   PubMed Web of Science ®Google Scholar
• Ferrer M, Liapikou A, Valencia M et al. Validation of the American Thoracic Society–Infectious Diseases Society of America guidelines for hospital-acquired pneumonia in the intensive care unit. Clin. Infect. Dis.50(7), 945–952 (2010).
   PubMed Web of Science ®Google Scholar
• Nseir S, Grailles G, Soury-Lavergne A, Minacori F, Alves I, Durocher A. Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission. Clin. Microbiol. Infect.16(7), 902–908 (2009).
   PubMed Web of Science ®Google Scholar
• Solomkin JS, Mazuski JE, Bradley JS et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg. Infect. (Larchmt.)11(1), 79–109 (2010).
   PubMed Web of Science ®Google Scholar
• Hooton TM, Bradley SF, Cardenas DD et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin. Infect. Dis.50(5), 625–663 (2010).
   PubMed Web of Science ®Google Scholar
• Leone M, Perrin A, Granier I et al. A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients. Intensive Care Med.33(4), 726–729 (2007).
   PubMed Web of Science ®Google Scholar
• Vincent J, Rello J, Marshall J et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA302(21), 2323–2329 (2009).
   PubMed Web of Science ®Google Scholar
• Căruntu FA, Benea L. Spontaneous bacterial peritonitis: pathogenesis, diagnosis, treatment. J. Gastrointestin. Liver Dis.15(1), 51–56 (2006).
   PubMedGoogle Scholar
• van de Beek D, de Gans J. Dexamethasone in adults with community-acquired bacterial meningitis. Drugs66(4), 415–427 (2006).
   PubMed Web of Science ®Google Scholar
• Arabi Y, Memish ZA, Balkhy HH et al. Ventriculostomy-associated infections: incidence and risk factors. Am. J. Infect. Control.33(3), 137–143 (2005).
   PubMed Web of Science ®Google Scholar
• Bouza E, Pérez A, Muñoz P et al. Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance. Crit. Care Med.31(7), 1964–1970 (2003).
   PubMed Web of Science ®Google Scholar
• Hayon J, Figliolini C, Combes A et al. Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med.165(1), 41–46 (2002).
   PubMed Web of Science ®Google Scholar
• Michel F, Franceschini B, Berger P et al. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest127(2), 589–597 (2005).
   PubMed Web of Science ®Google Scholar
• Blot S, Depuydt P, Vogelaers D et al. Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant Gram-negative bacteria in an intensive care unit. Infect. Control Hosp. Epidemiol.26(6), 575–579 (2005).
   PubMed Web of Science ®Google Scholar
• Depuydt PO, Blot SI, Benoit DD et al. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit. Crit. Care Med.34(3), 653–659 (2006).
   PubMed Web of Science ®Google Scholar
• Beardsley JR, Williamson JC, Johnson JW, Ohl CA, Karchmer TB, Bowton DL. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest130(3), 787–793 (2006).
   PubMed Web of Science ®Google Scholar
• Pea F, Viale P. Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock – does the dose matter? Crit. Care13(3), 214 (2009).
   PubMed Web of Science ®Google Scholar
• Marik PE, Lipman J, Kobilski S, Scribante J. A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients. J. Antimicrob. Chemother.28(5), 753–764 (1991).
   PubMed Web of Science ®Google Scholar
• Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit. Care Med.37(3), 840–851; quiz 859 (2009).
   PubMed Web of Science ®Google Scholar
• Roberts JA, Webb S, Paterson D, Ho KM, Lipman J. A systematic review on clinical benefits of continuous administration of β-lactam antibiotics. Crit. Care Med.37(6), 2071–2078 (2009).
   PubMed Web of Science ®Google Scholar
• Boselli E, Breilh D, Rimmelé T et al. Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia. Intensive Care Med.30(5), 989–991 (2004).
   PubMed Web of Science ®Google Scholar
• Albanèse J, Léone M, Bruguerolle B, Ayem ML, Lacarelle B, Martin C. Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit. Antimicrob. Agents Chemother.44(5), 1356–1358 (2000).
   PubMed Web of Science ®Google Scholar
• Georges B, Conil J, Seguin T et al. Population pharmacokinetics of ceftazidime in intensive care unit patients: influence of glomerular filtration rate, mechanical ventilation, and reason for admission. Antimicrob. Agents Chemother.53(10), 4483–4489 (2009).
   PubMed Web of Science ®Google Scholar
• Roberts JA, Lipman J. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis. Clin. Pharmacokinet.45(8), 755–773 (2006).
   PubMed Web of Science ®Google Scholar
• Moellering R, Mandel G, Bennet J, Dolin R. Principles of anti-infective therapy. In: Mandell, Douglas and Bennet’s Principles and Practice of Infectious Diseases 5th Edition. Churchill Livingstone, NY, USA (2000).
   Google Scholar
• Kumar A, Zarychanski R, Light B et al. Early combination antibiotic therapy yields improved survival compared to monotherapy in septic shock: a propensity-matched analysis. Crit. Care Med.38(9), 1773–1785 (2010).
   PubMed Web of Science ®Google Scholar
• Micek ST, Welch EC, Khan J et al. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrob. Agents Chemother.54(5), 1742–1748 (2010).
   PubMed Web of Science ®Google Scholar
• Kumar A, Safdar N, Kethireddy S, Chateau D. A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study. Crit. Care Med.38(8), 1651–1664 (2010).
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis.44(Suppl. 2), S27–S72 (2007).
   PubMed Web of Science ®Google Scholar
• Shefet D, Robenshtock E, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults. Cochrane Database Syst. Rev.2, CD004418 (2005).
   Google Scholar
• Heyland DK, Dodek P, Muscedere J, Day A, Cook D. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit. Care Med.36(3), 737–744 (2008).
   PubMed Web of Science ®Google Scholar
• Dupont H, Carbon C, Carlet J. Monotherapy with a broad-spectrum β-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group. Antimicrob. Agents Chemother.44(8), 2028–2033 (2000).
   PubMed Web of Science ®Google Scholar
• Montravers P, Dupont H, Gauzit R et al. Candida as a risk factor for mortality in peritonitis. Crit. Care Med.34(3), 646–652 (2006).
   PubMed Web of Science ®Google Scholar
• Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L. β-lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. Br. Med. J.328(7441), 668 (2004).
   PubMed Web of Science ®Google Scholar
• Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, Church DL. Severe bloodstream infections: a population-based assessment. Crit. Care Med.32(4), 992–997 (2004).
   PubMed Web of Science ®Google Scholar
• Marshall JC, Maier RV, Jimenez M, Dellinger EP. Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit. Care Med.32(Suppl. 11), S513–S526 (2004).
   PubMedGoogle Scholar
• Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. Antibiotic resistance among Gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA289(7), 885–888 (2003).
   PubMed Web of Science ®Google Scholar
• Depuydt P, Benoit D, Vogelaers D et al. Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures. Intensive Care Med.32(11), 1773–1781 (2006).
   PubMed Web of Science ®Google Scholar
• Shurland S, Zhan M, Bradham DD, Roghmann M. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect. Control Hosp. Epidemiol.28(3), 273–279 (2007).
   PubMed Web of Science ®Google Scholar
• Zahar J, Clec’h C, Tafflet M et al. Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia? Clin. Infect. Dis.41(9), 1224–1231 (2005).
   PubMed Web of Science ®Google Scholar
• Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, Kollef MH. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit. Care.10(3), R97 (2006).
   Web of Science ®Google Scholar
• Rello J, Sole-Violan J, Sa-Borges M et al. Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides. Crit. Care Med.33(9), 1983–1987 (2005).
   PubMed Web of Science ®Google Scholar
• Combes A, Luyt C, Fagon J et al. Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med.170(7), 786–792 (2004).
   PubMed Web of Science ®Google Scholar
• McNulty C, Logan M, Donald IP et al. Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. J. Antimicrob. Chemother.40(5), 707–711 (1997).
   PubMed Web of Science ®Google Scholar
• Niederman MS. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms. Clin. Infect. Dis.42(Suppl. 2), S72–S81 (2006).
   PubMed Web of Science ®Google Scholar
• Depuydt P, Blot S. Antibiotic therapy for ventilator-associated pneumonia: de-escalation in the real world. Crit. Care Med.35(2), 632–633 (2007).
   PubMed Web of Science ®Google Scholar
• Soo Hoo GW, Wen YE, Nguyen TV, Goetz MB. Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. Chest128(4), 2778–2787 (2005).
   PubMed Web of Science ®Google Scholar
• Rello J, Vidaur L, Sandiumenge A et al. De-escalation therapy in ventilator-associated pneumonia. Crit. Care Med.32(11), 2183–2190 (2004).
   PubMed Web of Science ®Google Scholar
• Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic ‘blind’ bronchoalveolar lavage fluid. Am. Rev. Respir. Dis.143(5 Pt 1), 1121–1129 (1991).
   PubMed Web of Science ®Google Scholar
• Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am. J. Respir. Crit. Care Med.162(2 Pt 1), 505–511 (2000).
   PubMed Web of Science ®Google Scholar
• Kollef MH, Kollef KE. Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results. Chest128(4), 2706–2713 (2005).
   PubMed Web of Science ®Google Scholar
• Chastre J, Wolff M, Fagon J et al. Comparison of 8 versus 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA290(19), 2588–2598 (2003).
   PubMed Web of Science ®Google Scholar
• Runyon BA, McHutchison JG, Antillon MR, Akriviadis EA, Montano AA. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology100(6), 1737–1742 (1991).
   PubMed Web of Science ®Google Scholar
• Hedrick TL, Evans HL, Smith RL et al. Can we define the ideal duration of antibiotic therapy? Surg. Infect. (Larchmt.)7(5), 419–432 (2006).
   PubMedGoogle Scholar
• Christ-Crain M, Jaccard-Stolz D, Bingisser R et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet363(9409), 600–607 (2004).
   PubMed Web of Science ®Google Scholar
• Schuetz P, Christ-Crain M, Thomann R et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA302(10), 1059–1066 (2009).
   PubMed Web of Science ®Google Scholar
• Bouadma L, Luyt C, Tubach F et al. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet375(9713), 463–474 (2010).
   PubMed Web of Science ®Google Scholar
• Kollef MH. Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit. Crit. Care9(5), 459–464 (2005).
   PubMed Web of Science ®Google Scholar
• Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit. Care Med.29(6), 1109–1115 (2001).
   PubMed Web of Science ®Google Scholar
• Dupont H, Mentec H, Sollet JP, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med.27(2), 355–362 (2001).
   PubMed Web of Science ®Google Scholar
• Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest125(5), 1791–1799 (2004).
   PubMed Web of Science ®Google Scholar
• Lipman J, Boots R. A new paradigm for treating infections: ‘go hard and go home’. Crit. Care Resusc.11(4), 276–281 (2009).
   PubMed Web of Science ®Google Scholar
• Shuman EK, Chenoweth CE. Recognition and prevention of healthcare-associated urinary tract infections in the intensive care unit. Crit. Care Med.38(Suppl. 8), S373–S379 (2010).
   Google Scholar
• Marshall JC, Innes M. Intensive care unit management of intra-abdominal infection. Crit. Care Med.31(8), 2228–2237 (2003).
   PubMed Web of Science ®Google Scholar
• Park DR. The microbiology of ventilator-associated pneumonia. Respir. Care.50(6), 742–763; discussion 763–765 (2005).
   PubMedGoogle Scholar
• Sarani B, Strong M, Pascual J, Schwab CW. Necrotizing fasciitis: current concepts and review of the literature. J. Am. Coll. Surg.208(2), 279–288 (2009).
   PubMed Web of Science ®Google Scholar
• Vallés J, Ferrer R. Bloodstream infection in the ICU. Infect. Dis. Clin. North Am.23(3), 557–569 (2009).
   PubMed Web of Science ®Google Scholar
• Beer R, Lackner P, Pfausler B, Schmutzhard E. Nosocomial ventriculitis and meningitis in neurocritical care patients. J. Neurol.255(11), 1617–1624 (2008).
   PubMed Web of Science ®Google Scholar
• Tunkel AR, Hartman BJ, Kaplan SL et al. Practice guidelines for the management of bacterial meningitis. Clin. Infect. Dis.39(9), 1267–1284 (2004).
   PubMed Web of Science ®Google Scholar
• Hooton TM, Bradley SF, Cardenas DD et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin. Infect. Dis.50(5), 625–663 (2010).
   PubMed Web of Science ®Google Scholar
• Tunkel AR, Glaser CA, Bloch KC et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis.47(3), 303–327 (2008).
   PubMed Web of Science ®Google Scholar